JP2019534709A5 - - Google Patents

Download PDF

Info

Publication number
JP2019534709A5
JP2019534709A5 JP2019537752A JP2019537752A JP2019534709A5 JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5 JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019537752 A JP2019537752 A JP 2019537752A JP 2019534709 A5 JP2019534709 A5 JP 2019534709A5
Authority
JP
Japan
Prior art keywords
isolated polynucleotide
polynucleotide molecule
rsv
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019537752A
Other languages
English (en)
Japanese (ja)
Other versions
JP7198759B2 (ja
JP2019534709A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/053047 external-priority patent/WO2018057950A1/en
Publication of JP2019534709A publication Critical patent/JP2019534709A/ja
Publication of JP2019534709A5 publication Critical patent/JP2019534709A5/ja
Priority to JP2022144109A priority Critical patent/JP7573001B2/ja
Application granted granted Critical
Publication of JP7198759B2 publication Critical patent/JP7198759B2/ja
Priority to JP2024178707A priority patent/JP2025020142A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019537752A 2016-09-23 2017-09-22 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補 Active JP7198759B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022144109A JP7573001B2 (ja) 2016-09-23 2022-09-09 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補
JP2024178707A JP2025020142A (ja) 2016-09-23 2024-10-11 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662399133P 2016-09-23 2016-09-23
US62/399,133 2016-09-23
US201662400476P 2016-09-27 2016-09-27
US62/400,476 2016-09-27
PCT/US2017/053047 WO2018057950A1 (en) 2016-09-23 2017-09-22 Vaccine candidates for human respiratory syncytial virus (rsv) having attenuated phenotypes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022144109A Division JP7573001B2 (ja) 2016-09-23 2022-09-09 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補

Publications (3)

Publication Number Publication Date
JP2019534709A JP2019534709A (ja) 2019-12-05
JP2019534709A5 true JP2019534709A5 (OSRAM) 2020-10-08
JP7198759B2 JP7198759B2 (ja) 2023-01-04

Family

ID=60009756

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019537752A Active JP7198759B2 (ja) 2016-09-23 2017-09-22 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補
JP2022144109A Active JP7573001B2 (ja) 2016-09-23 2022-09-09 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補
JP2024178707A Pending JP2025020142A (ja) 2016-09-23 2024-10-11 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022144109A Active JP7573001B2 (ja) 2016-09-23 2022-09-09 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補
JP2024178707A Pending JP2025020142A (ja) 2016-09-23 2024-10-11 弱毒化表現型を有するヒト呼吸器多核体ウイルス(rsv)のためのワクチン候補

Country Status (5)

Country Link
US (4) US10808012B2 (OSRAM)
EP (1) EP3515930A1 (OSRAM)
JP (3) JP7198759B2 (OSRAM)
AU (4) AU2017332789B2 (OSRAM)
WO (1) WO2018057950A1 (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4190895A1 (en) 2013-02-08 2023-06-07 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
AU2017332789B2 (en) 2016-09-23 2021-05-27 Codagenix, Inc. Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes
CN111511397A (zh) 2017-12-22 2020-08-07 科达金尼克斯有限公司 具有密码子对去优化区域的重组病毒及其用于治疗癌症的用途
CN112040977A (zh) 2018-03-08 2020-12-04 科达金尼克斯有限公司 减毒黄病毒
CA3178538A1 (en) 2020-05-13 2021-11-18 Peter L. Collins Rsv vaccine bearing one or more p gene mutations
EP4181956A4 (en) * 2020-07-16 2024-08-07 Griffith University VACCINE AGAINST A LIVE ATTENUATED VIRUS
KR20240004448A (ko) * 2021-04-08 2024-01-11 코다제닉스 인코포레이티드 호흡기 세포융합 바이러스에 대한 면역 반응을 유도하는 방법
WO2025054424A1 (en) * 2023-09-06 2025-03-13 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Human parainfluenza virus immunogenic molecules
WO2025128971A1 (en) 2023-12-14 2025-06-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Rsv vaccine bearing a polynucleotide which is de-optimised and de-attenuated

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224404A1 (de) 1982-06-30 1984-01-05 LuK Lamellen und Kupplungsbau GmbH, 7580 Bühl Reibungskupplung sowie verfahren zu deren montage
CA2230033C (en) 1995-09-27 2010-01-26 Peter L. Collins Production of infectious respiratory syncytial virus from cloned nucleotide sequences
CN101012454B (zh) 1996-07-15 2011-11-16 美国政府健康及人类服务部 从克隆的核苷酸序列制备减毒呼吸道合胞病毒疫苗的方法
AU7797798A (en) 1997-05-23 1998-12-11 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
JP2002541785A (ja) 1999-04-13 2002-12-10 アメリカ合衆国 クローン化ヌクレオチド配列からの弱毒化キメラ呼吸系発疹ウイルスワクチンの製造
WO2002042326A1 (en) 2000-11-22 2002-05-30 Biota Scientific Management Pty Ltd A method of expression and agents identified thereby
WO2006085987A2 (en) 2004-07-09 2006-08-17 University Of Iowa Research Foundation Rna interference in respiratory epitheial cells
DK3312272T3 (da) 2004-10-08 2019-12-02 Us Gov Health & Human Services Modulering af replikationstilpasning ved brug a mindre optrædende synonyme kodoner
EP2139515B2 (en) 2007-03-30 2023-12-20 The Research Foundation of the State University of New York Attenuated viruses useful for vaccines
US9011876B2 (en) 2008-11-05 2015-04-21 Merck Sharp & Dohme Corp. Live, attenuated respiratory syncytial virus
US10227569B2 (en) 2011-04-12 2019-03-12 Emory University Respiratory syncytial virus expression vectors
EP4190895A1 (en) 2013-02-08 2023-06-07 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Attenuation of human respiratory syncytial virus by genome scale codon-pair deoptimization
AU2017332789B2 (en) 2016-09-23 2021-05-27 Codagenix, Inc. Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes

Similar Documents

Publication Publication Date Title
JP2019534709A5 (OSRAM)
JP2016534034A5 (OSRAM)
IL276210B2 (en) Mers-cov vaccine
MX2020002876A (es) Metodo para la induccion segura de inmunidad contra el vsr.
JP2016539946A5 (OSRAM)
RU2016146801A (ru) Вакцинная композиция против инфекции, вызванной streptococcus suis
RU2019139064A (ru) Композиции и способы для лечения цитомегаловируса
JP2018504412A5 (OSRAM)
HRP20230694T1 (hr) Smanjenje ljudskog respiratornog sincicijskog virusa prema ljestvici genoma deoptimizacijom kodon-para
WO2014205579A4 (en) Modified matrix proteins of vesicular stomatitis virus
JP2010508030A5 (OSRAM)
EP2552490A4 (en) INFLUENZA MATRIX 2 PROTEIN ECKTOMOMAS, EXPRESSION SYSTEM THEREFOR AND USES THEREOF
JP2019500320A5 (OSRAM)
JP2019505567A5 (OSRAM)
JP2018524019A5 (OSRAM)
FI3511015T9 (fi) Geneettisesti stabiili elävä heikennetty respiratory syncytial -virusrokote ja sen tuottaminen
JP2015525794A5 (OSRAM)
JP2020515283A5 (OSRAM)
RU2018112060A (ru) Слитый белок
JP2012517239A5 (OSRAM)
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
JP2018536428A5 (OSRAM)
JP2020522249A5 (OSRAM)
JP6373601B2 (ja) アカバネウイルスに対して中和活性を有する抗体を誘導するペプチド
JP2018537103A5 (OSRAM)